首页 | 本学科首页   官方微博 | 高级检索  
     

腺病毒载体介导的内皮抑素基因治疗小鼠黑素瘤的实验研究
引用本文:曹瑞华,廖万清,温海,刘翠杰. 腺病毒载体介导的内皮抑素基因治疗小鼠黑素瘤的实验研究[J]. 中华皮肤科杂志, 2009, 42(8): 711-714. DOI: 10.3760/cma.j.issn.0412-4030.2009.10.020
作者姓名:曹瑞华  廖万清  温海  刘翠杰
作者单位:济南军区总医院皮肤科,250031;第二军医大学长征医院皮肤科;
摘    要:目的 探讨腺病毒载体介导的内皮抑素基因(Ad-mES)在体外和体内的生物学活性.方法 不同感染复度(MOI)的腺病毒体外感染靶细胞;RT-PCR法检测目的基因的表达;MTT法检测Ad-mES对靶细胞生物活性的影响.观察各组小鼠黑素瘤的生长、转移和生存率;免疫组化法鉴定肿瘤组织内内皮抑素蛋白的表达.电子透射电镜观察肿瘤组织内皮细胞、肿瘤细胞的凋亡情况.结果 腺病毒体外能够有效感染靶细胞,MOI为10,20,50,100,200,500时,B16F10细胞和ECV304细胞的腺病毒感染率分别为15.6%、35%、73%、88%、95.2%、97%和19%、35%、80%、90%、97%、98.5%.靶细胞明确表达内皮抑素基因;Ad-mES对B16F10细胞的增殖没有影响;而Ad-mES能抑制ECV304细胞的增殖,且随MOI增大,抑制内皮细胞增殖效果越强.瘤细胞接种后第8天,各组成瘤率100%.开始出现小鼠死亡的最早日:PBS组第16天、Ad-GFP组第18天、Ad-mES单剂、重复治疗组均在第20天.结论 Ad-mES体外和体内均影响靶细胞的生物学活性;Ad-mES治疗组小鼠平均生存时间延长(P<0.05),肿瘤体积增长减慢(P<0.05).

关 键 词:黑素瘤   内皮抑素类   基因疗法   

Adenovirus-mediated human endostatin gene delivery in the treatment of mouse melanoma
Abstract:Objective To observe the bioactivity of adenovirus-mediated human endostatin gene in vivo and in vitro.Methods B16F10 melanoma cells and human endothelial cells(ECV 304)were both transfected with recombinant adenovirus containing green fluorescent protein(Ad-GFP)or human endostatin gene (Ad-mES) at various multiplicity of infection(MOI).Then,the expression of endostatin gene was detected by RT-PCR,and the growth of cells by MTT assay.B16F10 cells were inoculated into the back of mice to establish melanoma models,which were classified into treated groups intratumorally injected with Ad-mES once (single Ad-mES group) or repeatedly(repetitive Ad-mES group)with an interval of 7 days,and control groups intratumorally injected with Ad-GFP (Ad-GFP group)or phosphate buffred solution (PBS group).Subsequently,the growth of tumors was observed at an interval of 4 days;tumor tissue samples were obtained from killed mice and subjected to the detection of endostatin expression with immunohistochemistry on day 7 after the first intratumoral injection;transmission electron microscopy was used to observe the apoptosis of tumor cells and endothelial cells on day 14.Results Adenovirus could efficiently infect targeted cells.When the MOI of Ad-GFP was 10,20,50,100,200 and 500,B16F10 cells were infected at a rate of 15.6%,35%,73%,88%,95.2%and 97%,respectively,and ECV304 cells at a rate of 19%,35%,80%,90%,97%and 98.5%,respectively.The endosmtin gene was proved to be expressed in targeted cells.Ad-mES had no obvious effect on B16F10 cells,but inhibited the growth of ECV 304 ceils,and the inhibitive effect was enhanced with the concentration of Ad-mES.The rate of tumor formation was 100% on day 8 after injection of B16F10 cells,and the earliest death of mice was observed on dav 16 in PBS group,day 18 in Ad-GFP group,day 20 in single Ad-mES group and repetive Ad-mES group.Conclusions The recombinant Ad-mES could affect the bioactivity of targeted cells in vivo and in vitro.Intratumoral injection of Ad-mES prolonged the survival of mice bearing melanoma and deccelarated the growth of melanoma.
Keywords:MelanomaEndostatinsGene therapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号